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Abstract
Background: Conjugated linoleic acid (CLA) has diverse influences on the immune response in
different experimental models. In the present study we investigated the effect of CLA feeding on
inflammatory and immune responses in a piglet model. We studied the duration of this effect and
possible detrimental effects of CLA feeding. After 12 weeks of CLA and control supplementation
and washout, animals were sacrificed and parenchymal organs were histologically examined.
Results: In activated peripheral mononuclear cells interferon- was significantly (p = 0.008) lower
in the CLA group by the end of the feeding period. This effect disappeared as soon as
supplementation was stopped. No differences were found in the tumour necrosis factor-,
interleukin-10 production, serum immunoglobulin-G levels and fat infiltration of the liver, except
that fat storage cell infiltration was significantly (p < 0.04) higher in the CLA-fed group. The effect
of time for interferon-, interleukin-10 and immunoglobulin-G levels was statistically significant.
Conclusion: At the end of the feeding period the interferon- response was depressed. However,
the maturation of the piglet immune system in our young pig model probably outweighs the impact
of CLA feeding on the immune response, even though liver fat storage cell infiltration, which plays
an important role in liver regeneration, increased during CLA feeding of the piglets.
Background
Conjugated linoleic acids (CLA) are naturally occurring
fatty acids found in dairy products and the meat of rumi-
nants. CLA isomers are formed in the rumen of ruminants
as intermediates in the hydrogenation of linoleic acid to
vaccenic acid, with the cis-9, trans-11 CLA isomer (c9, t11-
CLA) accounting for at least 90% of the possible isomers.
Polyunsaturated fatty acids are known to influence the
immune system. CLA, for instance, stimulates CD8+ lym-
phocytes and thymocytes. CLA also decreases inflamma-
tory tissue damage by modifying cell membranes and
influencing eicosanoid production and cell signalling
events [1,2]. However, different isomers have different
effects. Differences also exist among mammalian species,
with mice being the most sensitive [3,4]. Similarities
between pigs and humans makes the pig a frequently used
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model for CLA investigations [5-8]. In the pig model, it
was confirmed that dietary CLA prevents the elevation of
the proinflammatory cytokines interleukin-6 (IL-6) and
tumor necrosis factor- (TNF-), induced by the lipopol-
ysaccharide (LPS) challenge, but enhanced the expression
of interleukin-10 (IL-10) in the spleen and thymus [9]. IL-
10-mediated effects were dependent on the inhibition of
nuclear factor-B (NF-B) activation and it was demon-
strated that c9, t11-CLA enhanced this effect [10].
It has also been proven that CLA enhances cellular immu-
nity by modulating phenotype and effector functions of
CD8+ cells [6,8]. The CD4+ Th1 response has been stud-
ied in CLA-fed and porcine circovirus type 2 infected pigs,
and found to suppress interferon- (IFN-) production
[8]. Yet, on in vitro stimulated Jurkat cells, analysis of IL-2
and IFN- transcript levels showed increased expression of
both cytokines on CLA-treated cells [11]. After feeding
was completed, the immunomodulatory effect of dietary
CLA on the immune cell phenotype persisted 67 days,
compared to 25 days for effector functions [6].
However, CLA feeding seems to affect lipid accumulation
in different parechymal organs. Thus CLA affects accumu-
lation of lipids [12] and interconversion of fatty acids in
the mouse liver [13], but reduces hepatic steatosis in CLA
fed rats [14].
Because of these diverse influences of CLA on the immune
response and metabolism, we investigated the effect of
CLA feeding on the modulation of the inflammatory and
immune responses in a pig model in the present study.
The peripheral blood mononuclear cells (PBMC) of CLA
and non-CLA supplemented pigs were isolated and acti-
vated either by polyclonal activators (to assess the modu-
latory effect of CLA feeding on IFN- and IL-10
production) or by LPS to assess the modulation of TNF-.
The IFN- and IL-10 secretions were assessed in our own
model of in vitro cytokine production designed for moni-
toring the subtle changes in cytokine responses occurring
in vivo due to the pathological processes and/or immuno-
interventions in humans [15-17]. During the experiment
immunoglobulin-G (IgG) levels were measured. After the
feeding was completed the duration of any possible
immunomodulatory effect was also tested. Finally, the
effect of CLA feeding on lipid metabolism was evaluated
by the changes of the lipid content in the liver and kid-
neys.
Methods
Experimental animals, diets and design of the experiment
Twelve piglets of the Slovenian Landrace breed, weaned at
the age of nineteen days were used in the experiment. The
animals were randomly assigned into experimental and
control groups and housed in individual cages. Each
group of six piglets consisted of three females and three
male castrates. Initially they were fed "ad libitum" until
the age of 4 weeks with an experimental feed which con-
sisted of wheat (60%), maize (8%), barley (5%), extracted
soya bean meal (10%), fish meal (3%) and other special
protein concentrates (10%). The feed contained 13.5 MJ
of metabolic energy (ME), 18% of crude proteins with
12.5 g of Lysine per kg of feed, 2.95% crude fiber and
3.7% crude fats. The piglets were then weighted, the aver-
age weight at the beginning of supplementation was
found to be 6.66 kg and the average maintenance energy
(MaE) was calculated accordingly:
(MaE = maintenance energy in kJ/day, BM = body mass in
kg).
During the next phase of the experiment the piglets were
fed 1.8 times maintenance energy starting at an average
400 g of experimental feed per day per piglet. The piglets
were weighed every week and maintenance energy was
assigned individually at that time using the before men-
tioned MaE equation. Thus, between the 41 and 47 days
of age, the piglets received on average 560 g of feed daily,
between the ages of 48 and 54 days 630 g per day,
between the ages of 55 and 61 days 710 g per day,
between 62 and 68 days of age 800 g per day, and between
the ages of 69 and 76 days 870 g per day.
The experimental group of piglets received a 1.2% supple-
ment of a 50:50 mixture of c9, t11-CLA and trans-10, cis-
12 CLA (t10, c12-CLA) isomers (Larodan ABLimhamns-
gårdens alle 9, S-216 16 Malmö Sweden), i.e. 1.2 g of pure
CLA per 100 g of feed. Because the purity of CLA was only
80%, the CLA supplement was actually 1.5% (1.5 g per
100 g of feed). The control group received 1.5% sunflower
oil. After 5 weeks of supplementation, CLA isomer feeding
was stopped. In the last phase of the experiment, the pig-
lets were kept individually and fed on the same diet for the
remaining seven weeks without any supplement. Twelve
weeks after the start of supplementation all remaining pig-
lets were humanely sacrificed and necropsies were per-
formed to evaluate possible gross pathology lesions.
Samples of organs and tissues for further post-mortem
analyses were collected at the same time.
Isolation, preparation, ex vivo challenging of PBMC and 
IgG determination
Blood samples were taken every second week starting at
day 0 during CLA feeding and after the supplementation
ended. Peripheral blood mononuclear cells (PBMC) were
then isolated and treated for cytokine responses as previ-
ously described for human PBMC [15-19]. Piglet mono-
nuclear cells from each sample of venous blood with
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ethylenediaminetetracetic acid (EDTA) were isolated by
Ficoll-Paque (Phadia, Sweden) density gradient centrifu-
gation. The cells were suspended in RPMI 1640 supple-
mented with 100 U/ml penicillin, 100 g/ml
streptomycin, 2 mM L-glutamine and 5% heat-inactivated
foetal calf serum (Sigma, St. Louis, Missouri, USA) and
plated in 24-well cell culture plates (T grade, NUNC,
Roskilde, Denmark) to a final concentration of 6.66 ×
105/ml. To establish the TNF- response to the LPS chal-
lenge, PBMCs were incubated for 18 hours with LPS (from
E. coli, 0111:B4; Sigma, St. Louis, Missouri, USA), with a
final culture concentration of 10 ng/ml. Evaluation of the
IFN- response was performed by simultaneous polyclo-
nal activation by phorbol 12-myristat 13-acetate (PMA),
with a final concentration of 3.33 ng/ml, and ionomycin
(IONO), with a final concentration of 500 nM. Plates
were then incubated for 40 hours. Plates with LPS and
plates with IONO&PMA were incubated at 37°C, in a 5%
CO2 atmosphere and 95% humidity. The cell-free super-
natants were collected at 18 and 40 hours, respectively.
Supernatant samples were stored at -70°C before being
evaluated for three cytokines using commercially availa-
ble ELISA kits for measuring porcine TNF-, IFN- (Pierce
– Endogen, Rockford, IL, USA) and IL-10 (R&D Systems,
Minneapolis, MN, USA).
Total IgG was determined by serum dilution 1:32000 and
than measured using an ELISA kit (Abbott Co., Chicago,
IL., USA).
Pathoanatomical and histopathological examination
Whole body necropsies were performed on pigs from the
control group and those from the CLA-fed experimental
group. Parenchymal organs were weighted, examined and
samples of selected parenchymal organs collected for his-
topathological examination. The main target organ for the
study was the liver, due to its role in the metabolism of
lipids and its excretory function. During the necropsy
samples were taken from the four liver lobes (left and
right, lateral and medial lobes) and from the kidneys. Tis-
sue blocks for histopathology were fixed in 4% formalin
buffered with Di-sodiumhydrogenphosphate, Sodiumdi-
hydrogenphosphate and embedded in paraffin. Four m
thick tissue sections were stained with haematoxylin and
eosin (HE) for examination by light microscopy, while 10
m thick frozen sections of formalin-fixed liver and kid-
neys were stained for lipid content with Sudan III [20].
The distribution pattern within liver lobules (periportal,
midzonal, centrolobular) and localization within hepato-
cytes and fat-storing cells was determined for every liver
lobe. Quantification under light microscopy was subjec-
tive and the amount of lipid in liver and kidney was eval-
uated using light microscopy and the following
descriptive scale: 0 – negative, 1 – barely visible, 2 – mild,
3 – moderate, 4 – strong, 5 – very strong.
The ethics of the study protocol was approved by the Slov-
enian Veterinary Administration, Parmova ulica 53,
Ljubljana, Slovenia.
Statistical analysis
Descriptive statistics were calculated for all the observed
parameters. Two-way mixed analysis of variance
(ANOVA) was used to analyse the data with sampling day
as within-subject factor (6 levels) and group as between-
subjects factor (2 levels), whereby the Greenhouse-Geisser
correction was applied when Mauchy's test indicated sig-
nificant departure from the sphericity assumption. It
should be noted that if instead of ANOVA, analysis of cov-
ariance (ANCOVA) was used with day 0 as covariate and
only the remaining 5 sampling days as levels of the time
factor, the same conclusions were reached. Additionally,
independent sample t-tests were performed to asses the
difference in means between the two groups on each sam-
pling day except Day 0 (when any difference claimed
between the groups would be a Type I error by definition)
[21]. The mean liver infiltration was calculated for each
individual type of infiltration, after which a t-test was per-
formed to compare the control and CLA-fed groups. A
similar procedure was performed for the evaluation of
kidney tubular cell fat infiltration. A P  0.05 value was
considered statistically significant. All statistical analyses
were performed using SPSS for Windows software (ver-
sion 15.0.1.1., Chicago, IL, 2007).
Results
Immunological examination
ANOVA showed no significant effect of group or interac-
tion for IFN-, TNF-, IL-10 or IgG (Table 1, 2, 3, and 4).
The effect of time was statistically significant for IFN-, IL-
10 and IgG, thus indicating differences in response levels
between the sampling days for these parameters, whereby
the time-course did not differ significantly between the
groups.
Comparison between the control and CLA-fed groups at
each sampling day yielded a single P-value below 0.05,
namely for the IFN- response to polyclonal activation by
IONO&PMA by the end of the feeding period (at day 42),
when the measured level of IFN- was significantly lower
in the CLA-fed group (p = 0.008). This difference remains
significant even when adjusted for multiple tests using
Bonferroni correction (i.e., multiplied by 5).
Pathoanatomical and histopathological examination
Necropsy revealed no differences between the two groups.
These findings were confirmed histopathologically.Lipids in Health and Disease 2009, 8:22 http://www.lipidworld.com/content/8/1/22
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Histopathology of the lungs revealed some chronic,
mostly organised bronchointerstitial pneumonic lesions
in 5 pigs from the control and 6 from the CLA-fed group.
Acute pneumonic infiltrates were also identified in one
pig in the control and two in the CLA-fed group.
The liver was examined more closely. No significant dif-
ference in liver weight, expressed as a percentage of body
weight, was found between the groups, with an average of
1.73% in the control and 1.85% in the CLA-fed group (p
= 0.131).
Evaluation of the different distributions of liver fat infil-
tration revealed no significant differences between the
two groups, while the mean score of fat storage cell fat
infiltration was significantly higher in the CLA-fed group
(p < 0.04) (Table 5).
Evaluation of kidney tubular cell fat infiltration also
showed no significant difference between the groups, with
a mean score of 2.58 in the control and 1.07 in the CLA-
fed group (p = 0.072).
Discussion
In the present study, a notably decreased IFN- response
to polyclonal activation by IONO&PMA was found in the
CLA-fed group at the end of the feeding period. This effect
disappeared when the next post-feeding sample was
taken. No differences were found in the TNF- and IL-10
response to LPS and IONO&PMA ex vivo challenge
between CLA and non-CLA-fed pigs, as well as in serum
IgG levels. The ex vivo LPS and IONO&PMA challenge,
which we used in this study was, to our knowledge, also
the first ever performed on pigs in studies of the immuno-
logical influence of CLA. No difference in post-mortem
infection rate was found between our two groups of ani-
mals.
We noticed a statistically significant effect of time for IFN-
, IL-10 and IgG in both groups, thus indicating differ-
ences in response levels between the sampling days for
these parameters. This finding, however, is probably a
consequence of maturation of the piglet immune system,
which seems not to be influenced by CLA feeding, as it
does not affect the observed difference between the con-
trol group and the CLA-fed group on day 42. The fact that
no statistically significant effect of group or interaction
was found by ANOVA for any parameter (not even for
IFN-), can be attributed to the small sample size and rel-
atively large within-group variability, due to which the
between-group comparisons at individual days provided
valid additional information.
Some other studies on the immunological response to
CLA feeding have yielded a broad range of different
results. An CLA-fed porcine model was tested for cellular
immunity in vivo by vaccination and/or infection chal-
lenge, CD4+ and CD8+ T cells isolated from virally
infected pigs were studied for IFN- production on ex vivo
re-stimulation: CLA was found to suppressed IFN- pro-
duction in CD4+ but not in CD8+ T cells in these experi-
ments [5-8]. Fourteen day old piglets, in the experiment
Table 1: The effect of conjugated linoleic acid (CLA) on the porcine IFN- response.
Parameter and results of ANOVA Day Control group CLA group
IFN- (pg/ml) 0 3911 (4030) 6896 (3398)
14 9519 (8177) 5639 (4561)
Effect of P 28 7356 (3489) 9132 (3967)
Group 0.177 42# 12838 (6830) 3345 (1726)
Time 0.047* 56 10875 (6034) 14624 (6774)
Interaction 0.145 70 16873 (12310) 10660 (6501)
Descriptive statistics (mean and SD) and results of ANOVA, *P  0.05
# The comparison between groups that showed significant difference using t-test (p = 0.008) and after Bonferroni correction.
Table 2: The effect of conjugated linoleic acid (CLA) on the porcine TNF- response.
Parameter and results of ANOVA Day Control group CLA group
TNF- (pg/ml) 0 47.3 (79.9) 43.5 (45.5)
14 15.3 (6.1) 93.0 (98.2)
Effect of P 28 32.2 (17.5) 54.4 (49.3)
Group 0.105 42 53.9 (19.6) 78.0 (66.9)
Time 0.367 56 54.2 (31.8) 34.3 (24.9)
Interaction 0.417 70 87.6 (60.6) 98.6 (70.5)
Descriptive statistics (mean and SD) and results of ANOVALipids in Health and Disease 2009, 8:22 http://www.lipidworld.com/content/8/1/22
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which lasted 35 days, were used and in these studies the
importance of pig immune system maturation was not
taken into consideration [5]. Bassaganya-Riera et al. main-
tain that up to 35 days of dietary CLA supplementation
effects immature thymocites and only protracted feeding
modulates peripheral blood T cells. We kept our CLA feed-
ing for 35 days, after which we found transiently
depressed levels of IFN-, which is in accordance with Bas-
saganya-Riera's et al. finding, that IFN- production is sup-
pressed in CD4+ cells  [5,8]. Changhua et al. used a 28 day
old pig model to study the acute macrophage response.
They supplemented CLA for only 14 days and found
inhibitory actions of CLA on IL-1, IL-6, TNF- and
increased IL-10 levels after in vivo LPS stimulation in pigs,
which were attributable mainly to t10, c12-CLA [9]. In
contrast to Changhua et al., our LPS stimulation was car-
ried out ex vivo, and it is interesting that the effect on TNF-
 in our porcine experiment was the same as that in
humans stimulated ex vivo, where CLA had no effects on
ex vivo LPS-stimulated cytokine production [22]. In con-
trast to our results they also found an increase in IgG con-
centration of colostrums during dietary supplementation
with 0.5% CLA to sows during late gestation [23].
In rodents CLA has been demonstrated to suppress pro-
duction of proinflammatory cytokines, but individual iso-
mer supplementation also makes a difference [24,25].
Thus, lymphocytes isolated from c9, t11-CLA-fed mice
produced more TNF- than the control group. Yamasaki
et al. found that, compared with t10, c12-CLA, c9, t11-
CLA significantly stimulated TNF- production in spleen
lymphocytes of mice in vivo [26]. On the contrary, Yang
and Cook ascribed inhibition of LPS-induced TNF- pro-
duction in mice to c9, t11-CLA [2]. In terms of CLA influ-
ence on immunoglobulin production, mice fed t10, c12-
CLA produced more immunoglobulin A (IgA) and IgM
but not IgG [26]. However, omega-3 fatty acids have also
been found to influence IgG, but not IgA and IgM produc-
tion in rats [27].
In humans, daily consumption of 3 g of the c9, t11-CLA
or t10, c12-CLA isomer did not affect LPS-stimulated
cytokine production [22]. Likewise, CLA had no effects on
ex vivo cytokine production, but CLA supplementation did
reduce mitogen-induced activation of T lymphocytes [28].
In vitro experiments on human cells demonstrated that the
effects of CLA on cellular prostanoid formation can be
either inhibitory or stimulatory [29,30]. On the other
hand, CLA decreased TNF- and IFN- production after 12
weeks of feeding in humans in another study [31]. Differ-
ent influences of individual CLA isomers on immu-
noglobulin subclasses were also observed in humans
[32,33]. This leads to the impression that CLA might have
multiple, complex immunological effects in humans and
presumably also in pigs [30].
Thus, results of studies on the immunological role of CLA
are not uniform. It is therefore obvious that the immuno-
logical effect of CLA depends not only on the species, but
also on the gender, the CLA isomer used, duration of feed-
ing, whether the cells are in a resting or stimulated state
[1,30,31,34] and on in vivo versus in vitro immunological
stimulation.
Table 3: The effect of conjugated linoleic acid (CLA) on the porcine IL-10 response.
Parameter and results of ANOVA Day Control group CLA group
IL-10 (pg/ml) 0 9.1 (5.7) 14.6 (4.5)
14 12.2 (7.1) 10.68 (6.9)
Effect of P 28 9.20 (8.2) 15.47 (6.5)
Group 0.247 42 13.8 (7.7) 13.73 (4.6)
Time 0.045* 56 11.0 (7.4) 19.04 (7.8)
Interaction 0.489 70 20.1 (3.8) 22.6 (4.8)
Descriptive statistics (mean and SD) and results of ANOVA, *P  0.05
Table 4: The effect of conjugated linoleic acid (CLA) on the porcine serum IgG values.
Parameter and results of ANOVA Day Control group CLA group
IgG (mg/ml) 0 0.08 (0.03) 0.06 (0.03)
14 0.09 (0.03) 0.08 (0.02)
Effect of P 28 0.11 (0.03) 0.14 (0.03)
Group 0.914 42 0.08 (0.02) 0.08 (0.02)
Time 0.001* 56 0.19 (0.04) 0.23 (0.05)
Interaction 0.516 70 0.23 (0.04) 0.24 (0.03)
Descriptive statistics (mean and SD) and results of ANOVA, *P  0.05Lipids in Health and Disease 2009, 8:22 http://www.lipidworld.com/content/8/1/22
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Adverse side effects, such as insulin resistance, hyperin-
sulinaemia, inflammatory changes in adipocytes and liver
steatosis, have been reported mostly in mice, with some
evidence existing in humans. These effects are probably
due to t10, c12-CLA [35]. Our post-mortem investigation
of organs, with special emphasis on the lipid content in
the liver, failed to reveal any evidence of these effects.
However, morphological evaluation of the lipid distribu-
tion pattern and semiquantitative evaluation of the lipid
amount showed slightly higher, though insignificant,
amounts of fat in the liver of the control group. On the
other hand, a significant difference was found in the lipid
content of fat storing cells, where higher amounts were
found in the CLA-fed group. Fat storing cells, also called
hepatic stellate cells, are involved in the metabolism of
retinol and play an important role in liver regeneration
[36]. Hepatic stellate cells in arctic animals store 20–100
times the levels of retinol-palmitat lipid droplets as found
in humans and rats [37]. If we anticipate that Arctic ani-
mals consume more unsaturated fats, this could be in
agreement with our findings. Thus, CLA feeding probably
isn't detrimental to the pig liver as it has been shown to be
in some rodent models [13,38].
Conclusion
In our CLA-fed pigs, transitory immunomodulatory
effects were observed at the end of the feeding period with
a depression of the IFN- response. However, CLA feeding
had no effects on ex vivo LPS stimulation. Moreover, our
results indicate that the maturation of a piglet's immune
system probably outweighs the impact of CLA feeding on
their immune response. This should, therefore, be taken
into account by studies on the immune response of young
piglets. Our study also shows that the brief CLA feeding of
pigs has no other pathomorphological influence besides
that on hepatic fat storage cell fat infiltration, which seems
to have a hepatoprotective effect.
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